Pharmaceutical and Biotechnology companies are under increased pressure to advance compounds whilst ensuring safety and efficacy. It is essential to make faster go/no-go decisions on whether to continue their research before any major investments are made to progress drug development to later phases of research.
There are an increasing number of studies that require expert research sites dedicated to Phase I/II patient studies with the ability to manage complex protocols with intensive PK/PD procedures, patient assessments, and considerations around hospitalization. The increasing demands present the most difficult challenges for pharmaceutical and biotechnology companies in gaining reliable quality data in the shortest possible period.
To alleviate the challenges and to support the acceleration of drug development, over the last 10 years, ARENSIA has built up its own eight (8) research clinics, with full Phase I infrastructure. ARENSIA´s state-of-the-art clinics are entirely dedicated to perform most sophisticated Phase Ib / IIa / PROOF OF CONCEPT trials, exclusively in patients, across a variety of therapeutic areas. These research clinics are located within confined space in prestigious University and Private Hospitals in Romania, Republic of Moldova, Georgia, and Ukraine, with whom ARENSIA has been building deep relationships. This has allowed ARENSIA to achieve industry leading recruitment rates across numerous diseases, whilst maintaining the highest resulting data quality.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings